title: Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis.
abstract: The major sphingolipid metabolite, sphingosine-1-phosphate (S1P), has important biological functions. S1P serves as a ligand for a family of five G-protein-coupled receptors with distinct signaling pathways regulating important biological pathways. S1P induces renal fibrosis through an inflammatory pathway. However, its direct fibrosis-inducing effect on the kidney has not been shown. The role of S1P as a direct mediator of renal fibrosis was investigated in normal rat kidney interstitial fibroblast (NRK-49F) cells (in vitro) and kidneys of a unilateral ureteral obstruction (UUO) mouse model (in vivo). To clarify the role of S1P in renal fibrosis, we adopted nude UUO mice with immune response deficits. NRK-49F cells were stimulated with various concentrations of exogenous S1P and FTY720 (a S1P receptor agonist) or N,N-dimethylsphingosine (DMS; a sphingosine kinase inhibitor). C57BL6 and nude UUO mice were pretreated with FTY720, DMS, or saline. Expression levels of alpha-smooth muscle actin (a-SMA), E-cadherin, collagen type 1 (COL1), collagen type 4 (COL4), tissue inhibitor of matrix metalloproteinase-1 (TIMP1), and plasminogen activator inhibitor-1 (PAI1) were examined. S1P stimulated fibrosis in NRK-49F cells and UUO mice. Increased a-SMA, COL1, COL4, TIMP1, and PAI1 and decreased E-cadherin expression levels were observed in both the S1P-stimulated cells and UUO mice. Nude UUO mouse kidneys expressed fibrotic markers. Fibrotic changes were successfully induced in both UUO and nude UUO mice, evident through prominent fibronectin and COL1 staining. These S1P-induced fibrotic changes were suppressed by FTY720 and DMS both in vitro and in vivo. Thus, S1P essentially and directly mediates renal fibrosis.
authors.affiliation: Department of Medicine IV, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
authors.forename: Shunji
authors.initials: S
authors.lastname: Shiohira
authors.affiliation: Department of Medicine IV, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan ; Yoshida Medical Clinic, Suginami, Tokyo, Japan.
authors.forename: Takumi
authors.initials: T
authors.lastname: Yoshida
authors.affiliation: Department of Medicine IV, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Sugiura
authors.affiliation: Department of Medicine IV, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
authors.forename: Miki
authors.initials: M
authors.lastname: Nishida
authors.affiliation: Department of Medicine IV, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
authors.forename: Kosaku
authors.initials: K
authors.lastname: Nitta
authors.affiliation: Department of Medicine IV, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
authors.forename: Ken
authors.initials: K
authors.lastname: Tsuchiya
keywords: DMS; FTY720; UUO; renal fibrosis; sphingosine‐1‐phosphate
references.citation: J Lipid Res. 2009 Mar;50(3):556-564
references.pmid: 18955732
references.citation: Kidney Int. 2004 Oct;66(4):1434-43
references.pmid: 15458436
references.citation: Am J Respir Cell Mol Biol. 2007 Oct;37(4):395-404
references.pmid: 17641298
references.citation: Eur J Pharmacol. 2012 Dec 5;696(1-3):120-9
references.pmid: 23041148
references.citation: Int J Neurosci. 2013 Mar;123(3):163-9
references.pmid: 23167788
references.citation: Postepy Biochem. 2012;58(3):281-91
references.pmid: 23373414
references.citation: Mol Biol Cell. 2010 Mar 15;21(6):1111-24
references.pmid: 20089836
references.citation: Am J Pathol. 2007 Jan;170(1):281-92
references.pmid: 17200201
references.citation: Kidney Int. 2009 Oct;76(8):857-67
references.pmid: 19657322
references.citation: Pediatr Nephrol. 2012 Jun;27(6):901-9
references.pmid: 21947270
references.citation: Exp Eye Res. 2008 Oct;87(4):367-75
references.pmid: 18687328
references.citation: Pharmacol Ther. 2005 Dec;108(3):308-19
references.pmid: 15951022
references.citation: J Am Soc Nephrol. 2008 Feb;19(2):217-24
references.pmid: 18235102
references.citation: Kidney Int Suppl. 2010 Dec;(119):S22-6
references.pmid: 21116313
references.citation: Biochim Biophys Acta. 2013 Jan;1831(1):239-50
references.pmid: 22889995
references.citation: Br J Pharmacol. 2010 Feb 1;159(3):543-53
references.pmid: 20015089
references.citation: Biochem Pharmacol. 2008 May 15;75(10):1893-900
references.pmid: 18321471
references.citation: Wound Repair Regen. 2007 Sep-Oct;15(5):607-16
references.pmid: 17971005
references.citation: Am J Physiol Renal Physiol. 2006 Jun;290(6):F1516-24
references.pmid: 16403835
references.citation: Mol Cancer Res. 2008 Oct;6(10):1649-56
references.pmid: 18922980
references.citation: Clin Exp Nephrol. 2010 Dec;14(6):573-7
references.pmid: 20700620
references.citation: Lipids Health Dis. 2010 Feb 05;9:15
references.pmid: 20137073
references.citation: Drug Discov Today Dis Mech. 2007;4(1):55-59
references.pmid: 19448841
references.citation: Biochim Biophys Acta. 2008 Mar;1783(3):347-59
references.pmid: 18157950
references.citation: Am J Kidney Dis. 1994 Aug;24(2):172-80
references.pmid: 8048421
references.citation: Subcell Biochem. 2008;49:487-522
references.pmid: 18751924
references.citation: Fibrogenesis Tissue Repair. 2011 Feb 01;4(1):4
references.pmid: 21284856
references.citation: PLoS One. 2012;7(8):e43874
references.pmid: 22937115
references.citation: Cardiovasc Res. 2010 Feb 1;85(3):484-93
references.pmid: 19755413
references.citation: Am J Transplant. 2005 Jan;5(1):40-9
references.pmid: 15636610
references.citation: Contrib Nephrol. 2011;169:73-93
references.pmid: 21252512
references.citation: Expert Opin Ther Pat. 2013 Jul;23(7):817-41
references.pmid: 23541049
references.citation: Am J Physiol Renal Physiol. 2012 May 15;302(10):F1252-64
references.pmid: 22338084
references.citation: Ther Clin Risk Manag. 2013;9:73-85
references.pmid: 23483794